Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limited period of between three weeks and 30 months. T...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2020-06-01
|
| Series: | Pharmacy Practice |
| Subjects: | |
| Online Access: | https://pharmacypractice.org/journal/index.php/pp/article/view/1803 |